AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

Adenosquamous Cell Lung Cancer

3
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00368992
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
Completed · Phase 2
NCT00387374
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab
Completed · Phase 2
NCT00040794
Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
Completed · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Adenosquamous Cell Lung Cancer
🏥 Names
Disease Name
Adenosquamous Cell Lung Cancer
Alias Names
Adenosquamous Lung Carcinoma
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Respiratory Tract Diseases; Neoplasms
DO Class
disease of anatomical entity; disease of cellular proliferation
🔗 External References
Disease Ontology
4829
DisGeNET
C0279557
🔍 Raw view — every non-empty column on this row (25 fields)
name
Adenosquamous Cell Lung Cancer
alias name
Adenosquamous Lung Carcinoma
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Respiratory Tract Diseases; Neoplasms
do disease class
disease of anatomical entity; disease of cellular proliferation
umls disease type id
T191
mesh disease class id
C04; C08
do disease class id
DOID:14566; DOID:7
herb disease id
HBDIS007071
disgenet id
C0279557
do id
4829

⚗️ Related Ingredients

1 · shared evidence

📋 Clinical Trials

3 · subject of clinical study
NCT00368992 S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients
→ Adenocarcinoma of the Lung|Adenosquamous Cell Lung
NCT00387374 Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients
→ Adenosquamous Cell Lung Cancer|Drug/Agent Toxicity
NCT00040794 Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients
→ Adenocarcinoma of the Lung|Adenosquamous Cell Lung
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables